Recent Blog Posts

View Post: CANCER AND IMPORTANT MEDICAL NEWS: DOCETAXEL AND TRASTUZUMAB ...
3 hours ago by Dr. NICK  
NEW YORK (Reuters Health) Nov 19 - In women with node-positive or high-risk node-negative early breast cancer, disease-free survival was better when docetaxel was substituted for vinorelbine as an adjuvant therapy to fluorouracil, ...
View Blog: CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/

---

View Post: Adenocarcinoma of the Gastroesophageal Junction Clinical Trial ...
20 Nov 2009
It is not yet known whether vandetanib is more effective than a placebo when given together with oxaliplatin and docetaxel in treating advanced cancer of the esophagus or gastroesophageal junction. PURPOSE: This randomized phase I/II ...
View Blog: Clinical Trials Updates During the Last 7 Days - http://clinicaltrialsfeeds.org/clinical-trials/r...

---

View Post: Rapid PSA Decline After Docetaxel Chemotherapy is Associated with ...
11 Nov 2009 by Joel  
A chart review performed at the Department of Internal Medicine, University of Alberta, Edmonton, AB. concluded that the a quick rate of initial PSA decline in men with hormone refractory prostate cancer receiving docetaxel chemotherapy ...
View Blog: Advanced Prostate Cancer - http://advancedprostatecancer.net/

---

View Post: Threshold Pharmaceuticals Presents Interim Prostate Cancer Data ...
19 Nov 2009 by EIN Presswire: Press Releases News  
Prostate cancer is known to be hypoxic. Several years ago we furthered the support for the rationale of using TH-302 to treat prostate cancer when TH-302 was combined with docetaxel in a preclinical metastatic model of prostate cancer ...
View Blog: Business & Finance News - http://trak.in/india/

---

View Post: Prostate Cancer – Overall
1 hour ago by Omer Aslanbas  
The advent of docetaxel (Taxotere ) amended the therapeutic possibilities, Entr'ouvert by mitoxantrone (Novantrone ) some years earlier. For the first time, a drug used in advanced stages of the disease, managed to improve survival and ...
View Blog: Our Good Health - http://www.ourgoodhealth.org/

---

View Post: RCT: Adjuvant capecitabine in combination with docetaxel and ...
10 Nov 2009
The study involved 1500 women with axillary node-positive or high-risk node-negative breast cancer randomised to either 3 cycles of capecitabine and docetaxel followed by 3 cycles of cyclophosphamide, epirubicin, and capecitabine ...
View Blog: NeLM - News - http://www.nelm.nhs.uk/en/NeLM-Area/News/

---

View Post: 【医学英语】HER2，TOP2A，Ki67 and breast cancer_大牛哥_生命码_新浪博客
23 Nov 2009 by 大牛哥_生命码  
We analyzed the predictive value of Ki67, HER2, and progesterone receptor (PR) expression_r_r for the efficacy of docetaxel in patients with ER-positive, node-positive breast cancer. Patients and Methods expression_r_r of Ki67, HER2, ...
View Blog: 生命码 - http://blog.sina.com.cn/hanchengbo

---

View Post: Advanced Prostate Cancer В» Swift PSA Decline After Docetaxel
13 Nov 2009
Even though the issues between PSA testing and mammograms are exactly the same doctors, the American Cancer Society (ACS) and our government are all guilty of following the money and the political winds. Last month, Dr. ...
View Blog: zakbrown - http://www.liveinternet.ru/users/zakbrown/

---

View Post: Hospira Completes Decentralised Procedure for Generic Docetaxel ...
25 Oct 2009 by Prne  
Docetaxel is an anti-mitotic chemotherapy medication mainly used to treat breast cancer and prostate cancer. It is also used in lung cancer, head and neck cancer and gastric adenocarcinoma. Hospira's presentations of docetaxel will ...
View Blog: PR Hub - http://blog.taragana.com/pr/

---

View Post: Docetaxel Plus Dasatinib Versus Docetaxel Plus Placebo in ...
7 Oct 2009
Related Clinical Trials. Prostate Cancer. The purpose of this study is to determine whether survival can be prolonged in patients with castration-resistant prostate cancer who receive dasatinib in addition to docetaxel and prednisone. ...
View Blog: DukeHealth.org: Duke Clinical Trials - http://www.dukehealth.org/?utm_source=dukehealth.org&utm_m...

---